Hellwege, Jacklyn N.
Jeff, Janina M.
Wise, Lauren A.
Gallagher, C. Scott
Wellons, Melissa
Hartmann, Katherine E.
Jones, Sarah F.
Torstenson, Eric S.
Dickinson, Scott
Ruiz-Narváez, Edward A.
Rohland, Nadin
Allen, Alexander
Reich, David
Tandon, Arti
Pasaniuc, Bogdan
Mancuso, Nicholas
Im, Hae Kyung
Hinds, David A.
Palmer, Julie R.
Rosenberg, Lynn
Denny, Joshua C.
Roden, Dan M.
Stewart, Elizabeth A.
Morton, Cynthia C.
Kenny, Eimear E.
Edwards, Todd L.
Velez Edwards, Digna R.
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD074711, R03HD078567, R01HD060530, R01HD057966)
National Human Genome Research Institute (U01HG08672-01, U01HG006380)
National Cancer Institute (R25CA160056, R01CA58420, UM1CA164974, R01CA098663)
National Center for Advancing Translational Sciences (UL1TR000445)
National Heart, Lung, and Blood Institute (N01-HC-65226, HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, and HHSN268200900041C)
Article History
Received: 12 April 2017
Accepted: 16 August 2017
First Online: 23 August 2017
Change Date: 4 October 2017
Change Type: Erratum
Change Details: The article “A multi-stage genome-wide association study of uterine fibroids in African Americans”, written by Jacklyn N. Hellwege, was originally published Online First without open access. After publication in volume 136, issue 10, page 1363–1373 the author decided to opt for Open Choice and to make the article an open access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2017 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/ ), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Compliance with ethical standards
:
: DAH is an employee of and owns stock options in 23andMe, Inc. EAS declares the following financial competing interests: consultancy related to uterine fibroids: AbbVie, Allergan, Astellas, Bayer, and Gynesonics, Viteava. Patent applications (pending or actual), including individual applications or those belonging to the institution to which the authors, are affiliated and from which the authors may benefit. US 6440445 (With Nowak, RA, issued 2002, no commercial activity). Research Grants: NIH. R01HD060503, PI. P50 HS023418, Site PI for 3 component parts. R01HD074711, Consultant. K12HD065987, Board Member for Mayo Clinic Site. Other: Focused Ultrasound Surgery Foundation Borah(PI) 11/15/11-11/14/12 Costs of Uterine Fibroid Treatments Including Focused Ultrasound Surgery. Insightec Inc, PI Patient care costs in conjunction with R01HD60530. In addition, the following non-financial competing interests: relationship (paid or unpaid) with organizations and funding bodies including nongovernmental organizations, research institutions, or charities. Registry Steering Committee, REgistry for Leiomyoma International Efficacy of Focused Ultrasound (RELIEF). Writing or consulting for an educational company. Honoraria from: UpToDate, Massachusetts Medical Society.